0000921895-19-000636.txt : 20190304 0000921895-19-000636.hdr.sgml : 20190304 20190301201535 ACCESSION NUMBER: 0000921895-19-000636 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20190304 DATE AS OF CHANGE: 20190301 EFFECTIVENESS DATE: 20190304 FILER: COMPANY DATA: COMPANY CONFORMED NAME: PLx Pharma Inc. CENTRAL INDEX KEY: 0001497504 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 271707962 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-333941 FILM NUMBER: 19651528 BUSINESS ADDRESS: STREET 1: 8285 EL RIO STREET STREET 2: SUITE 130 CITY: HOUSTON STATE: TX ZIP: 77054 BUSINESS PHONE: (713) 842-1249 MAIL ADDRESS: STREET 1: 8285 EL RIO STREET STREET 2: SUITE 130 CITY: HOUSTON STATE: TX ZIP: 77054 FORMER COMPANY: FORMER CONFORMED NAME: Dipexium Pharmaceuticals, Inc. DATE OF NAME CHANGE: 20140313 FORMER COMPANY: FORMER CONFORMED NAME: Dipexium Pharmaceuticals, LLC DATE OF NAME CHANGE: 20100726 D 1 primary_doc.xml X0708 D LIVE 0001497504 PLx Pharma Inc. 8285 EL RIO STREET SUITE 130 HOUSTON TX TEXAS 77054 (713) 842-1249 DELAWARE Dipexium Pharmaceuticals, Inc. Dipexium Pharmaceuticals, LLC Corporation true Natasha Giordano 8285 EL RIO STREET SUITE 130 HOUSTON TX TEXAS 77054 Executive Officer Director Rita O'Connor 8285 EL RIO STREET SUITE 130 HOUSTON TX TEXAS 77054 Executive Officer Efthymios Deliargyris 8285 EL RIO STREET SUITE 130 HOUSTON TX TEXAS 77054 Executive Officer John W. Hadden II 8285 EL RIO STREET SUITE 130 HOUSTON TX TEXAS 77054 Director Michael J. Valentino 8285 EL RIO STREET SUITE 130 HOUSTON TX TEXAS 77054 Executive Officer Director Kirk Calhoun 8285 EL RIO STREET SUITE 130 HOUSTON TX TEXAS 77054 Director Robert Casale 8285 EL RIO STREET SUITE 130 HOUSTON TX TEXAS 77054 Director Gary Balkema 8285 EL RIO STREET SUITE 130 HOUSTON TX TEXAS 77054 Director Pharmaceuticals Decline to Disclose 06b false 2019-02-20 false true true true false 0 JMP Securities LLC 22208 None None 450 Park Avenue New York NY NEW YORK 10022 CA CALIFORNIA false 15000000 15000000 0 false 2 1050000 0 0 false PLx Pharma Inc. /s/ Rita O'Connor Rita O'Connor Chief Financial Officer 2019-03-01